Home > Boards > US Listed > Medical - Drugs > Dr. Reddy's Laboratories Limited (RDY)

News: $RDY Dr. Reddy's Laboratories Announces Acquisition of

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
whytestocks Member Profile
 
Followed By 55
Posts 7,611
Boards Moderated 0
Alias Born 06/04/18
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/1/2020 7:47:54 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/28/2020 7:17:59 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/22/2020 9:10:34 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/21/2020 7:14:33 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/21/2020 6:29:32 AM
Dr. Reddy’s Q4 & FY20 Financial Results Business Wire - 5/20/2020 6:45:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/18/2020 7:35:54 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/13/2020 6:36:24 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/8/2020 9:54:27 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/8/2020 9:41:55 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/7/2020 9:21:50 AM
Dr. Reddy's to release Q4 and full year FY 20 results on May 20, 2020 Business Wire - 5/7/2020 4:50:00 AM
Dr. Reddy's Laboratories Received Approval for Their NDA, ELYXYB™ (celecoxib oral solution) 25 mg/mL, in the U.S. Business Wire - 5/6/2020 1:15:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/6/2020 8:06:38 AM
Dr. Reddy's Laboratories Announces the Launch of Desmopressin Acetate Injection USP, 4 mcg/mL in the U.S. Market Business Wire - 5/6/2020 3:34:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/1/2020 12:53:12 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/29/2020 8:38:41 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/27/2020 7:28:29 AM
Dr. Reddy's Laboratories Announces the Launch of Fenofibrate Tablets USP, in the U.S. Market Business Wire - 4/27/2020 3:07:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/14/2020 8:14:16 AM
Dr. Reddy's Laboratories Announces the Launch of an Authorized Generic Version of NitroDur® (nitroglycerin) Transdermal Infu... Business Wire - 4/14/2020 5:22:00 AM
Dr. Reddy's Laboratories announces the launch of Amphetamine Sulfate Tablets USP, in the U.S. Market Business Wire - 4/14/2020 5:16:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/10/2020 8:40:19 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 4/9/2020 5:12:21 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/27/2020 1:27:46 PM
whytestocks   Saturday, 04/13/19 12:40:37 PM
Re: None
Post # of 18 
News: $RDY Dr. Reddy's Laboratories Announces Acquisition of ANDA Portfolio

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) announced today that it has entered into a definitive agreement to acquire a portfolio of 42 approved, non-marketed Abbreviated ...

Got this from https://marketwirenews.com/news-releases/dr-reddy-s-laboratories-announces-acquisition-of-anda-portfolio-7995468.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2020 InvestorsHub.com, Inc.